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ABSTRACT 
Optical imaging of genetically encoded probes has revolutionized biomedical studies by providing valuable 
information about targeted biological processes. Here, we report a novel imaging technique, termed reversibly 
switchable photoacoustic tomography (RS-PAT), which exhibits large penetration depth, high detection sensitivity, 
and super-resolution. RS-PAT combines advanced photoacoustic imaging techniques with, for the first time, a non-
fluorescent photoswitchable bacterial phytochrome. This bacterial phytochrome is the most near-infrared shifted 
genetically encoded probe reported so far. Moreover, this bacterial phytochrome is reversibly photoconvertible 
between its far-red and near-infrared light absorption states. Taking maximum advantage of the powerful imaging 
capability of PAT and the unique photochemical properties of the phytochrome, RS-PAT has broken through both the 
optical diffusion limit for deep-tissue imaging and the optical diffraction limit for super-resolution photoacoustic 
microscopy. Specifically, with RS-PAT we have achieved an unprecedented detection sensitivity of ~2 µM, or as few 
as ~20 tumor cells, at a centimeter depth. Such high sensitivity is fully demonstrated in our study by monitoring tumor 
growth and metastasis at whole-body level with ~100 µm resolution. Moreover, our microscopic implementation of 
RS-PAT is capable of imaging mammalian cells with a sub-diffraction lateral resolution of ~140 nm and axial 
resolution of ~400 nm, which are respectively ~2-fold and ~75-fold finer than those of our conventional photoacoustic 
microscopy. Overall, RS-PAT is a new and promising imaging technology for studying biological processes at 
different length scales.  
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1. INTRODUCTION 
Taking advantage of various optical contrasts in biological tissues, optical imaging techniques have provided valuable 
information for biomedical studies at different length scales [1]. However, strong optical scattering in tissue has led to 
substantial tradeoff between the spatial resolution and penetration depth. Photoacoustic (PA) tomography (PAT), on the 
contrast, has overcome the depth and resolution limitations of pure optical imaging, by acoustically detecting the optical 
absorption contrast [2]. PAT is inherently suited for molecular imaging, with a wealth of exogenous contrasts, such as 
organic dyes, nanoparticles, and fluorescent proteins [3]. However, systematically-administered organic dyes and 
nanoparticles present challenges in effective targeting and clearing [4-6]. Existing fluorescent proteins lack strong 
optical absorption at wavelengths beyond 750 nm, and thus are not suited for deep tissue imaging [7, 8]. Genetic 
encoding of eumelanin has also been explored in PAT [9, 10]. However, the heavy-burden pigmentation may jeopardize 
the cell growth, and that the endogenous melanin in tissue may degrade the imaging specificity. In addition, all the above 
contrasts sufferer from the strong background signals generated by various endogenous biomolecules, especially 
hemoglobin, which typically have wideband absorption spectra and are much more abundant in tissue [7, 8, 11]. The 
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highly wavelength-dependent light attenuation in tissue prevents spectroscopic unmixing at depths beyond the diffusion 
limit [12].    
Given these limitations, we develop a new approach that combines deep-penetration PA imaging with a novel non-
fluorescent bacteri-phytochrome BphP1, allowing high-resolution ultra-sensitive imaging of the genetically encoded 
biological process at depths. By photoconverting between the red-light-absorption Pr state and the NIR-light-absorption 
Pfr state, BphP1 is a natural reversible switch in light perception [13, 14]. Capitalizing on the strong NIR absorption of 
BphP1 and its switching capability between two states, we demonstrate that this method can significantly enhance the 
detection sensitivity of PAT. Tens of mammalian cells can be detected at ~1 cm depth. We further demonstrate this high 
detection sensitivity by imaging the growth of BphP1-expressing cancer cells in deep tissue in vivo and monitoring the 
cancer metastasis over an extended period of time. We also extended this method to optical-resolution PA microscopy, 
demonstrating substantially enhanced spatial resolution and image contrast on single bacteria, mammalian cells and mice.  
2. RESULTS 
2.1 Synthesis and characterization of BphP1  
Among phytochromes, BphP1 is one of the most attractive sources for PAT contrast because its absorption spectrum is 
the most red- shifted and because it utilizes biliverdin IVα (BV) as a chromophore. BphP1 can be effectively switched 
between the Pr-state and Pfr-state by light illumination at 630 nm and 780 nm, respectively. Biochemically, it is the bilin 
chromophore of BphP1 that absorbs light and changes the conformation of the attached protein, resulting in the 
switching from one state to the other (Figure 1a). Compared with other switchable photoreceptors that absorbs 
blue/ultra-violet light, including cryptochromes and phototropins, BphP1 is more suited for deep tissue imaging, with 
red-shifted absorption. BV is an intermediate of heme metabolism and is ubiquitously found in mammalian tissues, so 
BphP1 can be readily transfected in most biological systems [15]. However, because of its lack of fluorescence, wild-
type BphP1 has never been used in optical imaging [13]. 
 
Figure 1. Reversibly switchable BphP1 as a non-fluorescent genetically-encoded photoacoustic imaging contrast. (a) 
Photoswitching of BphP1 from Pr state to Pfr state, and vice versa, with the NIR and far-red illumination. (b) Absorption 
spectra of oxy-hemoglobin, deoxy-hemoglobin, Pr and Pfr state BhpP1, showing the strong NIR absorption of BphP1. (c) 
U87 cells expressing BphP1, with EGFP co-expressed for fluorescence imaging. (d) The PA images of an optically 
scattering and absorbing phantom with BphP1-expressing U87 cells embedded at 10 mm. The ON and OFF state images do 
not show the tumor cells due to the strong background signal, and the differential image clearly reveals the tumor cell 
signals. (e) Reversibly switching BphP1-expressing U87 cells in scattering media.  
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We investigated BphP1 in deep tissue imaging. Plastic tubes filled with protein or blood were embedded at different 
depths in scattering media, and imaged by PAT at their peak absorption wavelengths. The molar extinction coefficient of 
Pr-state BphP1 at 630 nm is ~40 times that of oxy-hemoglobin (HbO2), and Pfr-state BphP1 at 780 nm is ~70 times that 
of HbO2. We investigated BphP1 as a potential PA contrast, by using an upgraded whole-body PAT system (Figure 1b) 
[16]. To cover the absorption spectra of all the above proteins, an optical parametric oscillator (OPO) laser and a 
Ti:Sapphire laser were synchronized to provide an excitation spectrum from 400 nm to 800 nm. The signal amplitude at 
10 mm depth dropped by ~30 dB for BphP1 at 780 nm. Therefore, BphP1 is more suited for deep tissue imaging due to 
the weaker light attenuation at longer wavelength. We quantified the noise equivalent detection concentrations (NEC) of 
the proteins at different depths. An NEC of 2.7 µM has been achieved for BphP1 at 10 mm with a laser fluence of 8 
mJ/cm2, two orders of magnitude better than that of reported genetically encoded eumelanin at 600 nm [9]. 
We investigated the reversible switching of BphP1 between Pr- and Pfr-states, by measuring its optical absorbance at 
780 nm. We observed an exponential recovery from Pr-state to Pfr-state under 630 nm illumination, and an exponential 
decay from Pfr-state to Pr-state under 780 nm illumination. Such robust switching of BphP1 has allowed a simple 
differential operation on the PA images before and after the switching. The differential image can therefore suppress the 
background signal and enhance the image contrast [20]. Since hemoglobin is the dominant endogenous contrast in the 
visible-NIR spectral range, we further quantified the signal (protein) to background (blood) ratio at 10 mm depth. The 
results show that the differential image has substantially enhanced the contrast to noise ratio of BphP1 by ~25 times 
(Figure 1c). Multiple switching cycles did not cause photobleaching. The switching rate from Pf-state to Pfr-state is 
approximately proportional to the illumination light intensity at 630 nm, similar to other switchable chromophores [17-
19]. We observed robust switching of BphP1 at 10 mm depth without causing photobleaching (Figure 1d). 
2.2 In vivo high-sensitivity PAT of mammalian cells expressing BphP1 
BphP1 can be readily expressed in mammalian cells, requiring no enzymes or exogenous cofactors. Here, we 
permanently transfected U87 glioblastoma cells with BphP1 gene and EGFP gene. The average BphP1 expression 
concentration in U87 cells was estimated to be ~5 µM. Because BphP1 is non-fluorescent, EGFP is used for cell sorting 
and selection by fluorescence cytometry, and is also used for ex vivo validation of the in vivo PA imaging.  
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Figure 2. Deep PA imaging of a mouse brain tumor expressing BphP1. The ON and OFF state PA images of a nude mouse 
brain were acquired two weeks after the injection of U87 tumor cells at ~3 mm underneath the surface. The tumor is 
invisible in either the ON state or OFF state images due to the overwhelming background signals from blood. The 
differential image, by contrast, clearly shows the tumor by substantially suppressing background signals. The overlay image 
shows the BphP1 signal in color and the background blood signal in gray. 
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We investigated BphP1 for genetic encoded PA imaging in vivo. One million BphP1-expressing U87 cells were injected 
into the brain of a nude mouse, with the guidance of ultrasound imaging. Whole-body PA images were acquired one 
week after the inoculation of tumor cells (Figure 2). The BphP1-expressing U87 tumor in the brain could not be 
visualized in both the ON- and OFF-state PA images, due to the overwhelming blood signals. By contrast, the 
differential image clearly shows the tumor, with an average tumor-to-background ratio of ~20. While the tumor region 
has different signal amplitudes in the ON- and OFF-state images, the non-switchable background signals are identical. 
We harvested the brain and the histology confirmed the tumor region with higher cell density. We also demonstrated the 
three-dimensional imaging capability of PAT by stepping along the truck of a nude mouse bearing a BphP1-experessing 
U87 tumor in the flank. Although the elevational sectioning of current version PAT (~1 mm) is worse than its in-plane 
resolution (~100 µm), it can be improved by using three-dimensional imaging reconstruction and high frequency 
ultrasound detection [21]. 
2.3 Switchable photoacoustic microscopy with sub-diffraction resolution 
High scalability in both acoustic and optical domains is one of the most important advantages of PAT, allowing 
multiscale molecular imaging in vivo with the same optical contrast [2]. By focusing the excitation light, PAT has 
achieved optically-determined spatial resolution on the scale of micrometers and even submicrometers, within the optical 
diffusion limit. Here, we demonstrated that BphP1 can be used for optical-resolution PA imaging in vivo and for sub-
diffraction PA imaging of bacteria and mammalian cells, expanding genetically encoded PA imaging into cellular and 
subcellular domains. 
We demonstrated a sub-diffraction PA imaging method by using BphP1. This approach, termed switchable 
photoacoustic microscopy (SPAM), is based on the switching dynamics of BphP1. When a Gaussian-shape 780 nm light 
strikes ON-state Bphp1 molecules, the generated PA signal is a summation of the contributions from all molecules inside 
the excitation volume. During the excitation, the BphP1 molecules inside the excitation volume are inhomogeneously 
switched OFF, at a rate proportional to the local excitation intensity. Therefore, the PA signal from the center of the 
excitation volume decays faster than that from the periphery. In the polynomial fitting of the resultant PA signal decay, 
the high order coefficient highlights the signal contribution from the center of the excitation volume, and thus sharpens 
the resolution in all dimensions (Figure 3a) [22]. More importantly, SPAM can greatly block the out-of-focus signals for 
large targets, and thus enhance the image contrast. Notably, since BphP1 can be robustly cycled between the ON and 
OFF states, the whole imaging process is essentially lossless. 
Figure 3. Spatial-resolution enhancement in RS-PAM. (a) Principle of RS-PAM with subdiffraction resolution. In the 
diffraction-limited excitation volume, some ON-state BphP1 molecules (dots) are switched to the OFF state, where the 
switching-off rate is proportional to the local excitation intensity. By fitting the nonlinear signal-decay dynamics, RS-PAM 
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improves the spatial resolution in all dimensions. (b) Conventional (Conv.) PAM and RS-PAM images of BphP1-expressing 
bacteria densely fixed on a coverslip, showing the superior lateral resolution of RS-PAM. 
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The lateral resolution enhancement of SPAM was demonstrated on a monolayer of BphP1-experessing bacteria densely 
growing on a cover glass. Both conventional PAM and SPAM imaging were performed with a single switching cycle. 
Compared with the conventional PAM image, the SPAM image shows superior lateral resolution, allowing better 
separation of closely packed bacteria (Figure 3b). The lateral resolution enhancement was estimated to be 1.7 folds [23]. 
We demonstrated the axial resolution enhancement of SPAM on multilayer of live BphP1-expressing U87 cells (sample 
thickness: ~35 µm). For large targets, the conventional PAM relies on the poor axial resolution (~30 µm) provided by 
the time-resolved acoustic detection, and therefore was not able to resolve different layers of U87 cells. By contrast, 
SPAM was able to block the PA signals generated by out-of-focus cells and thus achieve optical sectioning (~0.4 µm). 
Cells at different depths were clearly resolved by SPAM. The axial resolution enhancement of SPAM is estimated to be 
~75 folds. 
3. DISCUSSION
In summary, we have demonstrated, for the first time, the combination of high-resolution deep-penetration PAT with the 
reversibly switchable non-fluorescent protein BphP1, which can offer a valuable means for high-sensitivity imaging of 
genetically encoded biological processes at different length scales. With this new approach, we have achieved a PA 
detection sensitivity of 2.7 µM of BphP1 or 20 mammalian cells at ~10 mm depth, and have monitored the tumor growth 
and metastasis at the whole-body level in vivo. We also demonstrated PA imaging of BphP1 with optically-determined 
resolution in vivo and sub-diffraction PA imaging on bacteria and mammalian cells. The high-sensitivity BphP1-based 
imaging in this study has demonstrated the practicality of genetically encoded PA imaging, and thus opened the 
possibility for a wide range of biomedical applications. For example, transgenetic mouse modes that express BphP1 in 
the neuron cells can be used for longitudinal PA monitoring of neural network development, with high imaging 
sensitivity and specificity [24]. It also provides a new opportunity to study the dynamic interaction between neurons and 
its supporting vascular network.  
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